Annual D&A
$7.00 M
-$577.00 K-7.62%
December 31, 2023
Summary
- As of February 12, 2025, HBIO annual depreciation & amortization is $7.00 million, with the most recent change of -$577.00 thousand (-7.62%) on December 31, 2023.
- During the last 3 years, HBIO annual D&A has fallen by -$634.00 thousand (-8.31%).
- HBIO annual D&A is now -10.90% below its all-time high of $7.85 million, reached on December 31, 2018.
Performance
HBIO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$1.81 M
+$14.00 K+0.78%
September 30, 2024
Summary
- As of February 12, 2025, HBIO quarterly depreciation & amortization is $1.81 million, with the most recent change of +$14.00 thousand (+0.78%) on September 30, 2024.
- Over the past year, HBIO quarterly D&A has increased by +$36.00 thousand (+2.02%).
- HBIO quarterly D&A is now -22.77% below its all-time high of $2.35 million, reached on December 31, 2018.
Performance
HBIO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$7.17 M
+$36.00 K+0.50%
September 30, 2024
Summary
- As of February 12, 2025, HBIO TTM depreciation & amortization is $7.17 million, with the most recent change of +$36.00 thousand (+0.50%) on September 30, 2024.
- Over the past year, HBIO TTM D&A has dropped by -$8000.00 (-0.11%).
- HBIO TTM D&A is now -12.20% below its all-time high of $8.17 million, reached on March 31, 2019.
Performance
HBIO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
HBIO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.6% | +2.0% | -0.1% |
| 3 y3 years | -8.3% | -3.4% | -5.8% |
| 5 y5 years | -10.9% | -6.8% | -7.2% |
HBIO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -8.2% | at low | -7.5% | +5.5% | -5.9% | +2.5% |
| 5 y | 5-year | -9.5% | at low | -7.5% | +5.5% | -7.5% | +2.5% |
| alltime | all time | -10.9% | >+9999.0% | -22.8% | +340.5% | -12.2% | +1641.3% |
Harvard Bioscience Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.81 M(+0.8%) | $7.17 M(+0.5%) |
| Jun 2024 | - | $1.80 M(+1.1%) | $7.14 M(+1.1%) |
| Mar 2024 | - | $1.78 M(+0.2%) | $7.06 M(+0.9%) |
| Dec 2023 | $7.00 M(-7.6%) | $1.78 M(-0.1%) | $7.00 M(-2.6%) |
| Sep 2023 | - | $1.78 M(+3.4%) | $7.18 M(-2.1%) |
| Jun 2023 | - | $1.72 M(0.0%) | $7.34 M(-1.5%) |
| Mar 2023 | - | $1.72 M(-12.2%) | $7.45 M(-1.7%) |
| Dec 2022 | $7.58 M(-0.6%) | $1.96 M(+1.3%) | $7.58 M(+0.5%) |
| Sep 2022 | - | $1.94 M(+5.8%) | $7.54 M(+0.8%) |
| Jun 2022 | - | $1.83 M(-1.0%) | $7.48 M(-1.1%) |
| Mar 2022 | - | $1.85 M(-3.9%) | $7.56 M(-0.8%) |
| Dec 2021 | $7.62 M(-0.1%) | $1.92 M(+2.3%) | $7.62 M(+0.0%) |
| Sep 2021 | - | $1.88 M(-1.7%) | $7.62 M(+0.4%) |
| Jun 2021 | - | $1.91 M(+0.1%) | $7.59 M(-0.5%) |
| Mar 2021 | - | $1.91 M(-0.6%) | $7.63 M(-0.0%) |
| Dec 2020 | $7.63 M(-1.3%) | $1.92 M(+4.0%) | $7.63 M(-0.3%) |
| Sep 2020 | - | $1.85 M(-5.3%) | $7.66 M(-1.3%) |
| Jun 2020 | - | $1.95 M(+2.1%) | $7.76 M(+1.1%) |
| Mar 2020 | - | $1.91 M(-1.8%) | $7.68 M(-0.7%) |
| Dec 2019 | $7.73 M(-1.5%) | $1.95 M(-0.1%) | $7.73 M(-5.0%) |
| Sep 2019 | - | $1.95 M(+4.2%) | $8.14 M(+0.9%) |
| Jun 2019 | - | $1.87 M(-5.0%) | $8.06 M(-1.3%) |
| Mar 2019 | - | $1.97 M(-16.3%) | $8.17 M(+4.0%) |
| Dec 2018 | $7.85 M(+106.6%) | $2.35 M(+25.2%) | $7.85 M(+22.0%) |
| Sep 2018 | - | $1.88 M(-5.0%) | $6.44 M(+16.1%) |
| Jun 2018 | - | $1.98 M(+19.7%) | $5.55 M(+22.2%) |
| Mar 2018 | - | $1.65 M(+76.4%) | $4.54 M(+19.4%) |
| Dec 2017 | $3.80 M(-11.1%) | $936.00 K(-4.8%) | $3.80 M(-1.4%) |
| Sep 2017 | - | $983.00 K(+1.5%) | $3.85 M(-2.9%) |
| Jun 2017 | - | $968.00 K(+5.9%) | $3.97 M(-3.6%) |
| Mar 2017 | - | $914.00 K(-7.6%) | $4.12 M(-3.6%) |
| Dec 2016 | $4.27 M(-6.5%) | $989.00 K(-10.1%) | $4.27 M(-6.2%) |
| Sep 2016 | - | $1.10 M(-1.5%) | $4.56 M(+1.0%) |
| Jun 2016 | - | $1.12 M(+4.6%) | $4.51 M(+0.7%) |
| Mar 2016 | - | $1.07 M(-16.0%) | $4.48 M(-2.1%) |
| Dec 2015 | $4.57 M(+17.9%) | $1.27 M(+20.6%) | $4.57 M(+4.1%) |
| Sep 2015 | - | $1.05 M(-2.9%) | $4.39 M(+2.8%) |
| Jun 2015 | - | $1.08 M(-6.7%) | $4.27 M(+4.4%) |
| Mar 2015 | - | $1.16 M(+6.8%) | $4.09 M(+5.6%) |
| Dec 2014 | $3.88 M(-2.8%) | $1.09 M(+16.3%) | $3.88 M(+3.4%) |
| Sep 2014 | - | $936.00 K(+3.3%) | $3.75 M(-0.5%) |
| Jun 2014 | - | $906.00 K(-4.3%) | $3.77 M(-2.6%) |
| Mar 2014 | - | $947.00 K(-1.4%) | $3.87 M(-3.0%) |
| Dec 2013 | $3.99 M(-5.2%) | $960.00 K(+0.4%) | $3.99 M(-2.6%) |
| Sep 2013 | - | $956.00 K(-4.9%) | $4.09 M(-1.6%) |
| Jun 2013 | - | $1.00 M(-5.9%) | $4.16 M(-1.1%) |
| Mar 2013 | - | $1.07 M(+0.2%) | $4.21 M(+0.0%) |
| Dec 2012 | $4.21 M | $1.07 M(+4.4%) | $4.21 M(-6.2%) |
| Sep 2012 | - | $1.02 M(-3.0%) | $4.48 M(-0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $1.05 M(-1.2%) | $4.50 M(+0.7%) |
| Mar 2012 | - | $1.07 M(-20.7%) | $4.47 M(+3.2%) |
| Dec 2011 | $4.33 M(+10.5%) | $1.34 M(+29.6%) | $4.33 M(+0.6%) |
| Sep 2011 | - | $1.04 M(+1.7%) | $4.30 M(+3.2%) |
| Jun 2011 | - | $1.02 M(+9.9%) | $4.17 M(+3.8%) |
| Mar 2011 | - | $928.00 K(-29.5%) | $4.01 M(+2.5%) |
| Dec 2010 | $3.92 M(+28.5%) | $1.32 M(+45.8%) | $3.92 M(+9.3%) |
| Sep 2010 | - | $903.00 K(+4.3%) | $3.58 M(+5.4%) |
| Jun 2010 | - | $866.00 K(+4.2%) | $3.40 M(+4.5%) |
| Mar 2010 | - | $831.00 K(-15.5%) | $3.25 M(+6.7%) |
| Dec 2009 | $3.05 M(-1.6%) | $984.00 K(+37.0%) | $3.05 M(+17.1%) |
| Sep 2009 | - | $718.00 K(-0.3%) | $2.60 M(-1.3%) |
| Jun 2009 | - | $720.00 K(+15.0%) | $2.64 M(-10.9%) |
| Mar 2009 | - | $626.00 K(+15.9%) | $2.96 M(-4.3%) |
| Dec 2008 | $3.10 M(-10.9%) | $540.00 K(-28.3%) | $3.10 M(-11.2%) |
| Sep 2008 | - | $753.00 K(-27.9%) | $3.49 M(-3.9%) |
| Jun 2008 | - | $1.04 M(+37.5%) | $3.63 M(+6.0%) |
| Mar 2008 | - | $759.00 K(-18.4%) | $3.42 M(-1.5%) |
| Dec 2007 | $3.47 M(+4.1%) | $930.00 K(+4.1%) | $3.47 M(-0.2%) |
| Sep 2007 | - | $893.00 K(+6.4%) | $3.48 M(+2.7%) |
| Jun 2007 | - | $839.00 K(+3.3%) | $3.39 M(-0.6%) |
| Mar 2007 | - | $812.00 K(-13.3%) | $3.41 M(+2.2%) |
| Dec 2006 | $3.34 M(-33.8%) | $937.00 K(+16.7%) | $3.34 M(+8.9%) |
| Sep 2006 | - | $803.00 K(-6.6%) | $3.06 M(-9.5%) |
| Jun 2006 | - | $860.00 K(+16.7%) | $3.39 M(-18.3%) |
| Mar 2006 | - | $737.00 K(+11.0%) | $4.15 M(-17.7%) |
| Dec 2005 | $5.04 M(-20.6%) | $664.00 K(-41.0%) | $5.04 M(-17.4%) |
| Sep 2005 | - | $1.13 M(-30.5%) | $6.10 M(-2.4%) |
| Jun 2005 | - | $1.62 M(-0.6%) | $6.25 M(-2.2%) |
| Mar 2005 | - | $1.63 M(-5.7%) | $6.39 M(+0.7%) |
| Dec 2004 | $6.35 M(+20.0%) | $1.73 M(+35.7%) | $6.35 M(+4.5%) |
| Sep 2004 | - | $1.27 M(-27.7%) | $6.07 M(+1.4%) |
| Jun 2004 | - | $1.76 M(+11.1%) | $5.99 M(+7.0%) |
| Mar 2004 | - | $1.58 M(+9.2%) | $5.60 M(+5.9%) |
| Dec 2003 | $5.29 M(+75.7%) | $1.45 M(+21.7%) | $5.29 M(+11.2%) |
| Sep 2003 | - | $1.19 M(-13.1%) | $4.76 M(+8.8%) |
| Jun 2003 | - | $1.37 M(+7.5%) | $4.37 M(+18.3%) |
| Mar 2003 | - | $1.27 M(+38.9%) | $3.69 M(+22.7%) |
| Dec 2002 | $3.01 M(+1.3%) | $918.00 K(+13.9%) | $3.01 M(-3.4%) |
| Sep 2002 | - | $806.00 K(+16.0%) | $3.12 M(-3.0%) |
| Jun 2002 | - | $695.00 K(+17.6%) | $3.21 M(+2.0%) |
| Mar 2002 | - | $591.00 K(-42.3%) | $3.15 M(+6.0%) |
| Dec 2001 | $2.97 M(+99.4%) | $1.02 M(+13.8%) | $2.97 M(+52.7%) |
| Sep 2001 | - | $901.00 K(+42.3%) | $1.95 M(+86.2%) |
| Jun 2001 | - | $633.00 K(+53.6%) | $1.04 M(+153.6%) |
| Mar 2001 | - | $412.00 K | $412.00 K |
| Dec 2000 | $1.49 M(+18.6%) | - | - |
| Dec 1999 | $1.26 M(+4555.2%) | - | - |
| Dec 1998 | $27.00 K | - | - |
FAQ
- What is Harvard Bioscience annual depreciation & amortization?
- What is the all time high annual D&A for Harvard Bioscience?
- What is Harvard Bioscience annual D&A year-on-year change?
- What is Harvard Bioscience quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Harvard Bioscience?
- What is Harvard Bioscience quarterly D&A year-on-year change?
- What is Harvard Bioscience TTM depreciation & amortization?
- What is the all time high TTM D&A for Harvard Bioscience?
- What is Harvard Bioscience TTM D&A year-on-year change?
What is Harvard Bioscience annual depreciation & amortization?
The current annual D&A of HBIO is $7.00 M
What is the all time high annual D&A for Harvard Bioscience?
Harvard Bioscience all-time high annual depreciation & amortization is $7.85 M
What is Harvard Bioscience annual D&A year-on-year change?
Over the past year, HBIO annual depreciation & amortization has changed by -$577.00 K (-7.62%)
What is Harvard Bioscience quarterly depreciation & amortization?
The current quarterly D&A of HBIO is $1.81 M
What is the all time high quarterly D&A for Harvard Bioscience?
Harvard Bioscience all-time high quarterly depreciation & amortization is $2.35 M
What is Harvard Bioscience quarterly D&A year-on-year change?
Over the past year, HBIO quarterly depreciation & amortization has changed by +$36.00 K (+2.02%)
What is Harvard Bioscience TTM depreciation & amortization?
The current TTM D&A of HBIO is $7.17 M
What is the all time high TTM D&A for Harvard Bioscience?
Harvard Bioscience all-time high TTM depreciation & amortization is $8.17 M
What is Harvard Bioscience TTM D&A year-on-year change?
Over the past year, HBIO TTM depreciation & amortization has changed by -$8000.00 (-0.11%)